1257266-74-2

Basic information

• Product Name: (2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pentanoic acid benzyl ester
• Synonyms: (2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pentanoic acid benzyl ester
• CAS NO: 1257266-74-2
• Molecular Weight: 473.612
• Mol File: 1257266-74-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pentanoic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pentanoic acid benzyl ester(1257266-74-2)
• EPA Substance Registry System: (2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pentanoic acid benzyl ester(1257266-74-2)

Safety Data

• Hazardous Substances Data: 1257266-74-2(Hazardous Substances Data)

Upstream product

• 1012341-50-2 (2R,4S)-5-[(1,1‘-biphenyl)-4-yl]-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid 
• 100-39-0 benzyl bromide 

Downstream Products

• 1257265-27-2 (2R,4S)-4-amino-5-biphenyl-4-yl-2-methylpentanoic acid benzyl ester hydrochloride 

Relevant articles and documents

Pharmaceutical composition and compound for treatment on hypertension and heart failure

The invention relates to a pharmaceutical composition and compound for treatment on hypertension and heart failure and their preparation method and use and belongs to the field of pharmaceutical compositions. The pharmaceutical composition comprises an active ingredient N comprising at least one selected from a compound shown in the formula (I), its isomer, prodrug and pharmaceutically acceptable salt and their solvate, and an active ingredient A comprising at least one selected from a compound shown in the formula (II), its isomer, prodrug and pharmaceutically acceptable salt and their solvate. The pharmaceutical composition and compound have good therapeutic effects and a wide application prospect.